Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis | Zendy

Herman Kwok | Zendy; Wayne Khuu | Zendy; Kimberly A. Fernandes | Zendy; Diana Martins | Zendy; Mina Tadrous | Zendy; Samantha Singh | Zendy; David N. Juurlink | Zendy; Tara Gomes | Zendy

Open Access

Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis

Author(s) -

Herman Kwok,

Wayne Khuu,

Kimberly A. Fernandes,

Diana Martins,

Mina Tadrous,

Samantha Singh,

David N. Juurlink,

Tara Gomes

Publication year - 2016

Publication title -

pain medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.893

H-Index - 97

eISSN - 1526-4637

pISSN - 1526-2375

DOI - 10.1093/pm/pnw351

Subject(s) - pregabalin , medicine , medical prescription , concomitant , population , formulary , cross sectional study , anesthesia , family medicine , pharmacology , environmental health , pathology

Access to pregabalin via Ontario's public drug insurance program was expanded to an unrestricted model on April 1, 2013, from a prior authorization model. This study aims to identify the effect of expanded access on the rate of pregabalin use by publicly insured persons and to assess the characteristics of new patients initiating pregabalin following this expanded access.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research